Terminated PHASE2 INTERVENTIONAL 2-arm NCT00373581

Effects of Vigabatrin on Cocaine Self-Administration

Sponsor: New York State Psychiatric Institute

Updated 6 times since 2017 Last updated: Oct 25, 2016 Started: Apr 30, 2006 Primary completion: Dec 31, 2006 Completion: Dec 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Funding ran out

Other terminated trials from New York State Psychiatric Institute

See all terminations from New York State Psychiatric Institute

Other Cocaine Dependence trials with similar outcome

NCT01802515 · Phase NA · Mar 2014

Browse all Cocaine Dependence trials

This PHASE2 trial investigates Cocaine Dependence and is currently terminated or withdrawn. New York State Psychiatric Institute leads this study, which shows 6 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Terminated PHASE2

First recorded

Apr 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

New York State Psychiatric Institute
Novel Cocaine Pharmacotherapies

Data source: New York State Psychiatric Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States